首页 | 本学科首页   官方微博 | 高级检索  
     

雷诺拉嗪联合地尔硫革对稳定性心绞痛的疗效评价
引用本文:田才林,刘岳怀. 雷诺拉嗪联合地尔硫革对稳定性心绞痛的疗效评价[J]. 中国现代医生, 2012, 50(5): 122-123
作者姓名:田才林  刘岳怀
作者单位:1. 浙江省平湖市第二人民医院心内科,浙江平湖,314200
2. 浙江大学医学院附属第二医院心内科,浙江杭州,310009
摘    要:目的探讨雷诺拉嗪联合地尔硫革治疗稳定性心绞痛的临床疗效和安全性。方法86例稳定性心绞痛患者随机分为观察组49例和对照组37例,对照组给予地尔硫革治疗,观察组在此基础上加用雷诺拉嗪。结果观察组临床总有效率和心电图总有效率分别为89.80%和87.76%,对照组临床总有效率和心电图总有效率为83.78%和83.78%,差异具有统计学意义(P〈0.05)。两组均无不良反应发生。结论雷诺拉嗪联合地尔硫革治疗稳定性心绞痛疗效确切、副作用少、使用安全、值得推广使用。

关 键 词:雷诺拉嗪  地尔硫卓  稳定性心绞痛

Effect of ranolazin and dihiazem on patients with stable angina pectoris
TIAN Cailin , LIU Yuehuai. Effect of ranolazin and dihiazem on patients with stable angina pectoris[J]. Journal China Modern Doctor, 2012, 50(5): 122-123
Authors:TIAN Cailin    LIU Yuehuai
Affiliation:1.Department of Cardiology,the Second People’s Hospital of Pinghu City in Zhejiang Province,Pinghu 314200,China;2.Department of Cardiology the Second Affiliated Hospital to Zhejiang University,Hangzhou 310009,China
Abstract:Objective To explore the therapeutic effect and security of ranolazin and dihiazem on patients with stable angina pectoris.Methods All of 86 patients with stable angina pectoris were randomly divided into observtion group(49 cases) and control group(37 cases).The control group was given dihiazem,and the observtion group was given dihiazem and ranolazin.Results The clinical and electrocardiographic total effective rate were 89.80% and 87.76% of the observtion group,compared with 83.78% and 83.78% of the control group.It was better.There was a evident difference between the groups(P < 0.05).There were not any adverse effect in the tow groups.Conclusion It is accurate,safe to treat stable angina pectoris with ranolazin and dihiazem,and it is worth spreading clincally.
Keywords:Ranolazin  Dihiazem  Stable angina pectoris
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号